These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 728912)

  • 21. Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel.
    Schultz RM; Chirigos MA; Pavlidis NA; Youngner JS
    Cancer Treat Rep; 1978 Nov; 62(11):1937-41. PubMed ID: 103619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further observations on the inhibition of tumor growth by corynebacterium parvum with cyclophosphamide.
    Fisher B; Rubin H; Wolmark N
    J Natl Cancer Inst; 1976 Aug; 57(2):317-22. PubMed ID: 1003514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a growing tumor and its removal on the cytotoxicity of macrophages from cultured bone marrow cells.
    Fisher B; Wolmark N; Coyle J; Saffer EA
    Cancer Res; 1976 Jul; 36(7 PT 1):2302-5. PubMed ID: 1277133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
    Fisher B; Wolmark N; Rubin H
    J Natl Cancer Inst; 1976 Jul; 57(1):225-6. PubMed ID: 1003505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.
    Wolmark N; Levine M; Fisher B
    J Reticuloendothel Soc; 1974 Oct; 16(4):252-7. PubMed ID: 4455907
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG.
    Yamazaki M; Saito M; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bladder tumor model response to immunotherapy.
    deKernion JB; Ramming KP; Fraser K
    Natl Cancer Inst Monogr; 1978 Dec; (49):333. PubMed ID: 748789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. I. Variation in administration of both agents.
    Fisher B; Wolmark N; Rubin H; Saffer E
    J Natl Cancer Inst; 1975 Nov; 55(5):1147-53. PubMed ID: 1206740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancer.
    Vanhaelen CP; Fisher RI
    Cancer Res; 1981 Mar; 41(3):980-3. PubMed ID: 7193085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. II. Effect of cortisone acetate.
    Fisher B; Rubin H; Saffer E; Wolmark N
    J Natl Cancer Inst; 1976 Mar; 56(3):571-4. PubMed ID: 1255788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.
    Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM
    Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity to chemotherapeutic and immunomodulating agents of two mouse lymphomas and of a macrophage tumor.
    Tarnowski GS; Ralph P; Stock CC
    Cancer Res; 1979 Oct; 39(10):3964-7. PubMed ID: 476634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of the non-specific resistance by Corynebacterium parvum and Bacillus calmette Guérin.
    Ruitenberg EJ; Steerenberg PA
    Tijdschr Diergeneeskd; 1976 Jul; 101(14):775-8. PubMed ID: 821172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice.
    Lynch NR; Salomon JC
    J Natl Cancer Inst; 1979 Jan; 62(1):117-21. PubMed ID: 281566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.
    Evans R
    Am J Pathol; 1980 Jun; 99(3):667-84. PubMed ID: 7386598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.